申请人:Sandoz Pharmaceuticals Corp.
公开号:US05162311A1
公开(公告)日:1992-11-10
The invention discloses certain substituted .alpha.-aminoacids having the formula ##STR1## where m and n are 1 or 2, and R, R.sub.1, R.sub.2, R.sub.3 and Y have various significances, which compounds are useful in treating epilepsy, disorders associated with excess GH or LH secretion, anxiety, schizophrenia, depression, CNS degenerative disorders, cerebral hypoxic conditions and stress-related psychiatric disorders.
该发明揭示了具有以下结构式的某些取代的α-氨基酸##STR1##其中m和n为1或2,R、R.sub.1、R.sub.2、R.sub.3和Y具有各种含义,这些化合物在治疗癫痫、与过多GH或LH分泌相关的疾病、焦虑、精神分裂症、抑郁症、中枢神经系统退行性疾病、脑缺氧症和与压力相关的精神障碍方面是有用的。